Patents by Inventor Jacob Torres

Jacob Torres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200289444
    Abstract: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
    Type: Application
    Filed: March 14, 2020
    Publication date: September 17, 2020
    Applicants: The Regents of the University of California, Augusta University Research Institute
    Inventors: Weimbs Thomas, Jacob Torres, Muthusamy Thangaraju
  • Publication number: 20200121948
    Abstract: Disclosed herein are methods for personalized treatment of individual patient tumors. In one embodiment, a method of calculating a personalized radiation therapy dosage for a subject comprises determining expression levels of one or more signature genes from a subject's tumor sample, applying a linear regression model to the gene expression levels and assigning a radiation sensitivity index (RSI) to the subject's tumor sample, calculating a genomic adjusted radiation dose (GARD) value based on RSI, radiation dose and fractionation schedule of the subject, and calculating a personalized radiation dosage (RxRSI) for the subject based on a pre-determined GARD value.
    Type: Application
    Filed: October 21, 2019
    Publication date: April 23, 2020
    Applicant: CVERGENX, INC.
    Inventors: Jacob G. Scott, Javier Torres-Roca